Skip to content
Trial Eligibility
Menu

NON-INVASIVE BRAIN STIMULATION FOR MEMORY LOSS IN EARLY ALZHEIMER'S DISEASE

NCT07667478

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The goal of this clinical trial is to learn if repetitive transcranial magnetic stimulation (rTMS), a non-invasive form of brain stimulation, can improve short-term memory in people with early Alzheimer's disease (AD). The study will also evaluate the safety of this approach. The main questions it aims to answer are: Does rTMS applied to the cerebellum improve short-term memory in people with early AD? How does this stimulation affect brain activity and connectivity measured by MRI?

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Alzheimer s Disease
  • Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease
  • Mild Dementia

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
55 to 90 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
Chi-Ying (Roy) Lin
Last updated on ClinicalTrials.gov
October 1, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Texas · 1

  • Baylor College of Medicine · Houston, TX

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.